Comparative antimicrobial activity of piperacillin-tazobactam tested against more than 5000 recent clinical isolates from five medical centers a reevaluation after five years
- 1 March 1995
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 21 (3) , 153-168
- https://doi.org/10.1016/0732-8893(95)00019-7
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- National survey of the in vitro spectrum of piperacillin-tazobactam tested against more than 40,000 aerobic clinical isolates from 236 medical centersDiagnostic Microbiology and Infectious Disease, 1995
- Prevalence of important pathogens and the antimicrobial activity of parenteral drugs at numerous medical centers in the united states II. Study of the intra- and interlaboratory dissemination of extended-spectrum β-lactamase-producing EnterobacteriaceaeDiagnostic Microbiology and Infectious Disease, 1994
- Prediction of piperacillin-tazobactam susceptibility among Enterobacteriaceae, pseudomonas aeruginosa, and other bacteria using ticarcillin-clavulanic acid, ceftazidime, and other broad-spectrum antimicrobial in vitro test resultsDiagnostic Microbiology and Infectious Disease, 1994
- Multicenter evaluation of the in vitro activity of piperacillin-tazobactam compared with eleven selected β-lactam antibiotics and ciprofloxacin against more than 42,000 aerobic gram-positive and gram-negative bacteriaDiagnostic Microbiology and Infectious Disease, 1994
- A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamins, penicillins, clindamycin, and metronidazole in the United StatesDiagnostic Microbiology and Infectious Disease, 1994
- Behaviour of β-lactamase-positive and -negative Staphylococcus aureus isolates in susceptibility tests with piperacillin/tazobactam and other β-lactam/β-lactamase inhibitor combinationsJournal of Antimicrobial Chemotherapy, 1993
- Tazobactam prevention of emergence of resistanceDiagnostic Microbiology and Infectious Disease, 1989
- Activity of ticarcillin/clavulanate and piperacillin/tazobactam (YTR 830; CL-298,741) against clinical isolates and against mutants derepressed for class I beta-lactamaseDiagnostic Microbiology and Infectious Disease, 1989
- Studies to optimize the in vitro testing of piperacillin combined with tazobactam (YTR 830)Diagnostic Microbiology and Infectious Disease, 1989
- Comparative in vitro activity of piperacillin combined with the beta-lactamase inhibitor tazobactam (YTR 830)Diagnostic Microbiology and Infectious Disease, 1989